RecruitingNot ApplicableNCT06878287
Bright Light Therapy During Residential Alcohol Withdrawal
Bright Light Therapy During Residential Alcohol Withdrawal : a Double Blind Randomized Placebo Controlled Study
Sponsor
Centre Hospitalier St Anne
Enrollment
100 participants
Start Date
May 31, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
This is a randomized controlled trial assessing the effectiveness of light therapy versus placebo in patients undergoing alcohol withdrawal.
Eligibility
Min Age: 18 YearsMax Age: 65 Years
Inclusion Criteria5
- Patients must be aged from 18 to 65 years old and have a diagnosis of Alcohol Use Disorder
- Patients must be intreated for alcohol withdrawal, for at least two weeks
- Patients must report heavy drinking episodes in the past month
- Patients must be able to understand medical information and consent to the treatment
- Patients must be considering a goal of abstinence from alcohol
Exclusion Criteria7
- Ophthalmic pathology (cataract, macular degeneration, glaucoma, retinitis pigmentosa) and diseases affecting the retina (retinopathy, diabetes, herpes, etc.)
- Subjects who have already received light therapy in the last 6 months
- Lactating of pregnant women
- Psychiatric comorbidity requiring an intreatment, or risk of manic episode (subjects with depressive or anxious symptoms compatible with an out-treatment can be included)
- Substance Use Disorder other than alcohol and/or tobacco
- Severe cognitive impairment (MOCA < 10)
- Patients being under legal protection measure
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERLight exposure
30 minutes morning exposure to light (10 000 lux) using a light-box device filtering UV (CE marking)
OTHERPlacebo light
30 minutes exposure to the same device using a filter inactivating light intensity (\< 10 lux)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06878287
Related Trials
Environment and Alcohol: A Pilot Study
NCT068606071 location
Behavioral and Functional Task Development, Implementation, and Testing
NCT021080541 location
NIAAA Natural History Protocol
NCT022318401 location
Semaglutide Therapy for Alcohol Reduction (STAR)
NCT060158931 location
StuDy AimED at Increasing AlCohol AbsTinEnce
NCT057787341 location